Active Trial Portfolio

About M3 Wake Research

M3 Wake Research is a well-established, privately held clinical research organization (CRO) site network that has been operating for over 30 years. As a wholly-owned subsidiary of the Japanese digital health giant M3, Inc., it leverages a unique integrated model of owned and operated research sites to efficiently recruit participants and conduct trials for industry sponsors. The company has demonstrated significant scale, having completed 674 studies and enrolled over 19,000 participants in the last five years across numerous therapeutic indications. Its business model is centered on providing clinical trial services, positioning it as a critical execution partner in the drug development value chain.

Therapeutic Areas